About this episode
Jeremy Gardner joins us on the Mycopreneur podcast to share insights about the roles of technology and venture capital in shaping the psychedelic ecosystem of the future. After tremendous early success as a crypto investor, Jeremy has diversified his investments into a range of asset classes and ventures - which includes the emergent psychedelic industry. We dive into a range of topics from artificial intelligence to the future of masculinity to psilocybin mushroom macrodoses, as well as considerations for where to invest in the emergent psychedelics space.
Please consider rating, reviewing, and sharing the podcast with a friend.
Hosted on Acast. See acast.com/privacy for more information.
Get every episode summarized
Each time Mycopreneur publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Mycopreneur
Lee Carroll: Ergothioneine in Support of Psychedelic Therapy
Mycopreneur
Adam Miezio: Psychedelics in the Epstein Files
Mycopreneur
Robert Gallery: Ibogaine For Athletes with Traumatic Brain Injuries
Mycopreneur
Melanie Tremblay: The Hidden Dangers of AI-Generated Mushroom Claims
Mycopreneur